These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 789845)

  • 1. Theophylline pharmacokinetics in premature infants with apnea.
    Giacoia G; Jusko WJ; Menke J; Koup JR
    J Pediatr; 1976 Nov; 89(5):829-32. PubMed ID: 789845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn.
    Latini R; Assael BM; Bonati M; Caccamo ML; Gerna M; Mandelli M; Marini A; Sereni F; Tognoni G
    Eur J Clin Pharmacol; 1978 May; 13(3):203-7. PubMed ID: 668774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of theophylline in the treatment of apnea of prematurity.
    Sims ME; Yau G; Rambhatla S; Cabal L; Wu PY
    Am J Dis Child; 1985 Jun; 139(6):567-70. PubMed ID: 3890520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic aspects of theophylline in premature newborns.
    Aranda JV; Sitar DS; Parsons WD; Loughnan PM; Neims AH
    N Engl J Med; 1976 Aug; 295(8):413-6. PubMed ID: 934239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of theophylline in low birth weight newborn infants].
    Cottancin G; Baltassat P; Bory C; Challamel MJ; Frederich A
    Pediatrie; 1977; 32(7):677-84. PubMed ID: 928035
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M; Lipowsky G; Stöckl H; Stiegler H
    Monatsschr Kinderheilkd; 1981 Dec; 129(12):697-702. PubMed ID: 7329425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen consumption in apneic premature infants after low-dose theophylline.
    Milsap RL; Krauss AN; Auld PA
    Clin Pharmacol Ther; 1980 Oct; 28(4):536-40. PubMed ID: 7408413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of apnea and bradycardia in low-birthweight infants.
    Shannon DC; Gotay F; Stein IM; Rogers MC; Todres ID; Moylan FM
    Pediatrics; 1975 May; 55(5):589-94. PubMed ID: 236535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-dosage loading concentrations of theophylline and pharmacokinetic study after the fifth maintenance dosage in premature newborns with apnea].
    Rodríguez-Palomares C; Udaeta-Mora E; González-Treviño J; Juárez-Olguín H; Calderón-Mandujano B; Prado-Serrano A; Belmont-Gómez A
    Bol Med Hosp Infant Mex; 1991 Mar; 48(3):164-72. PubMed ID: 2064746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM; Jusko WJ; Koup JR; Giacoia G
    Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preventive treatment with theophylline of apnea in premature infants: clinical, pharmokinetic and neurophysiological study].
    Demarquez JL; Brachet-Lierman A; Paty J; Deliac MM; Philippe JC; Maix M; Babin JP; Martin C
    Arch Fr Pediatr; 1978; 35(7):793-805. PubMed ID: 736736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants.
    Brouard C; Moriette G; Murat I; Flouvat B; Pajot N; Walti H; de Gamarra E; Relier JP
    Am J Dis Child; 1985 Jul; 139(7):698-700. PubMed ID: 4014092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.
    Jones RA; Baillie E
    Arch Dis Child; 1979 Mar; 54(3):190-3. PubMed ID: 434904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data.
    Jamali F; Barrington KJ; Finer NN; Coutts RT; Torok-Both GA
    Dev Pharmacol Ther; 1988; 11(5):253-7. PubMed ID: 3191816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma xanthine levels in low birthweight infants treated or not treated with theophylline.
    Brazier JL; Renaud H; Ribon B; Salle BL
    Arch Dis Child; 1979 Mar; 54(3):194-9. PubMed ID: 434905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].
    Alix D; Berthou F; Riche C; Gouedard H
    Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of caffeine in infants unresponsive to theophylline in apnea of prematurity.
    Davis JM; Spitzer AR; Stefano JL; Bhutani V; Fox WW
    Pediatr Pulmonol; 1987; 3(2):90-3. PubMed ID: 3588062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration-effect relationship of theophylline in treatment of apnea in preterm infants.
    Lagercrantz H; Rane A; Tunell R
    Eur J Clin Pharmacol; 1980 Jul; 18(1):65-8. PubMed ID: 7398750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA
    Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.